In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Angioplasty for Intracranial Atherosclerotic Disease Involving Posterior Circulation: A Meta-Analysis of All Cases Reported in the Literature

    Final Number:
    1090

    Authors:
    Hussain Shallwani MBBS; Kunal Vakharia MD; Jason Davies MD PhD; Adnan Hussain Siddiqui MD, PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Intracranial atherosclerotic disease (ICAD) is one of the common causes of ischemic stroke worldwide. Notably, the risk of recurrent stroke is also higher in patients with ICAD, as compared to stroke due to other causes. It is therefore imperative to address and treat the underlying ICAD, in order to decrease the risk of subsequent transient ischemic attack (TIA) and strokes. Posterior circulation stroke and stenosis is associated with 2.5-15% stroke risk per year and 33% in the first month after symptoms are noticed in some studies with best medical management.

    Methods: Out of the total 154 eligible abstracts and full-length papers, 67 studies met our inclusion criteria and the data from these studies were included in our meta-analysis. A total of 599 subjects and 611 lesions were identified that underwent angioplasty for the treatment of posterior circulation ICAD.

    Results: This data of available literature suggests that angioplasty for symptomatic ICAD may be able to dilate the vessel and achieve technical success (defined as <50% stenosis) in approximately 74% of cases. The rate of peri-procedural complications was defined as the occurrence of dissection, vasospasm, TIA, stroke, hemorrhage or death within 30-days of the procedure. The rate of peri-procedural complications is 26% in our results, a significant portion can be attributed to dissection of the vessel (9%). Angioplasty techniques and devices have drastically changed over the years, with some studies showing the technical success rates over 90% and 30-day major complication rates below 6%.

    Conclusions: Submaximal angioplasty, providing higher success rates and lower peri-procedural complication rates, may be considered the next step for these patients to prevent recurrent ischemic complications. Further randomized trials are needed for better assessment of this procedure in patients with posterior circulation ICAD.

    Patient Care: It opens up discussion for sub maximal angioplasty for posterior circulation ICAD.

    Learning Objectives: - the natural history of posterior circulation ICAD - the problems with treatment of posterior circulation ICAD - the benefits of angioplasty and possible future directions

    References: 1. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med. 1985;313(19):1191-200. 2. Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, Boden-Albala B, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2009;28(1):65-71. 3. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26(1):14-20. 4. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 2005;65(2):296-8. 5. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40(10):1541-5. 6. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111(10):1327-31. 7. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27(11):1974-80. 8. Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106-14. 9. Komotar RJ, Wilson DA, Mocco J, Jones JE, Connolly Jr ES, Lavine SD, et al. Natural history of intracranial atherosclerosis: a critical review. Neurosurgery. 2006;58(4):595-601. 10. Wong K. CLAIR study investigators: Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489-97. 11. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305-16. 12. Sundt TM, Jr., Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc. 1980;55(11):673-80. 13. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. Journal of neurosurgery. 2002;97(6):1294-301. 14. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, et al. Angioplasty for symptomatic intracranial stenosis clinical outcome. Stroke. 2006;37(4):1016-20. 15. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis Outcome of patients who fail antithrombotic therapy. Neurology. 2000;55(4):490-8. 16. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993-1003. 17. McTaggart RA, Marks MP. The case for angioplasty in patients with symptomatic intracranial atherosclerosis. Front Neurol. 2014;5:36. 18. Weimar C, Goertler M, Harms L, Diener HC. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol. 2006;63(9):1287-91. 19. Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angioplasty and stenting in the awake patient. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2006;16(3):216-23. 20. Bendok BR, Sherma AK, Hage ZA, Das S, Naidech AM, Surdell DL, et al. Periprocedural MRI perfusion imaging to assess and monitor the hemodynamic impact of intracranial angioplasty and stenting for symptomatic atherosclerotic stenosis. J Clin Neurosci. 2010;17(1):54-8. 21. Berg-Dammer E, Henkes H, Weber W, Berlit P, Kuhne D. Percutaneous transluminal angioplasty of intracranial artery stenosis: clinical results in 24 patients. Neurosurgical focus. 1998;5(4):e13. 22. Dumont TM, Sonig A, Mokin M, Eller JL, Sorkin GC, Snyder KV, et al. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. Journal of neurosurgery. 2016:1-8. 23. Hatano T, Tsukahara T. Endovascular treatment for intracranial vertebrobasilar artery stenosis. Acta neurochirurgica Supplement. 2014;119:83-9. 24. Hussain MS, Fraser JF, Abruzzo T, Blackham KA, Bulsara KR, Derdeyn CP, et al. Standard of practice: endovascular treatment of intracranial atherosclerosis. J Neurointerv Surg. 2012;4(6):397-406.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy